FDA recall record

Huijing (Shanghai) Bio-tech Co Acne Treatment Pads (2% salicylic acid) recall — FDA D-1076-2018

Subpotent drug: The product active ingredient level not matching the exact levels indicated on the packaging label.

Class IIIclassification
D-1076-2018official record ID
Aug 22, 2018report date

Recall record at a glance

Official recordD-1076-2018
CategoryDrug Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmHuijing (Shanghai) Bio-tech Co., Ltd.
Report dateAug 22, 2018
Recall initiation dateAug 3, 2018
Quantity75,000 pads
LocationShanghai, China

Official product description

Acne Treatment Pads (2% salicylic acid), packaged in a 50-count jar, OTC, Distributed by: Greenbrier International, Inc. 500 Volvo Parkway, Chesapeake, VA 23320, NDC 71537-001-02

Why the product was recalled

Subpotent drug: The product active ingredient level not matching the exact levels indicated on the packaging label.

Distribution information

Product was distributed to one distributor in VA

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.